TASK ORDER 4R - ENVIRONMENTAL AUTOIMMUNITY GROUP (EAG) - STUDY SUPPORT
任务顺序 4R - 环境自身免疫组 (EAG) - 研究支持
基本信息
- 批准号:10630801
- 负责人:
- 金额:$ 19.87万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-06-01 至 2023-05-31
- 项目状态:已结题
- 来源:
- 关键词:AccountabilityAdverse eventAdvertisingAmendmentAutoantibodiesAutoimmunityAwardBackBiologicalBiological Specimen BanksBiopsyBloodClinicalClinical Laboratory Information SystemsClinical ResearchClinical ServicesClinical Trials DatabaseClinical assessmentsCollaborationsCollectionConflict of InterestConsentConsent FormsContractorDNADataData AnalysesData CollectionData ReportingDatabasesDevelopmentDiagnosisEnrollmentEnsureEnvironmental Risk FactorEquipment and supply inventoriesEvaluationExperimental PathologyFractionationFunding AgencyHealthHobbiesHumanImageInternationalLaboratoriesLigaseMonitorMyositisNational Institute of Environmental Health SciencesNursing ResearchOccupationsOutcomeParentsParticipantPatientsPerformancePeriodicityPeripheral Blood Mononuclear CellPhysiciansPlasmaProceduresProcessProtocols documentationQuestionnairesRNARecordsRegulationReportingResearchResearch AssistantResearch PersonnelResearch SupportResearch TrainingSamplingSerumServicesShipsSigns and SymptomsSiteSpecimenSpottingsSurveysSyndromeTest ResultTimeTissuesUnited States Department of Veterans AffairsUnited States Food and Drug AdministrationUnited States National Institutes of HealthUpdateVisitWhole BloodWorkdata cleaningdemographicsinterestmaterial transfer agreementmemberpatient screeningpatient subsetsperformance siteprogramsrecruitrepositoryresearch studyresponsesample collectionscreening
项目摘要
The purpose of this task order is to provide overall administrative, clinical and research support,
statistical, database and repository management, and regulatory assistance for all Environmental Autoimmunity Group (EAG) clinical studies. This includes: subject screening, evaluation and disposition; completion of protocol forms as needed; arranging and managing onsite and offsite enrollment processes; database creation, fusion and updating; data cleaning and analyses; sample collection and storage, deliveries, and processing; ensuring completion of all questionnaires and consent revisions as needed per any Standard Operating Procedure (SOP) or other changes and other administrative processes needed per Health and Human Services, De partment of Defense, Food and Drug Administration, Veteran’s Affairs, any other oversight
agencies and other collaborating entities’ rules and regulations.
This Task Order will provide support to the EAG clinical studies, where services can be classified
as Severable and non-Severable, the performance period required for completion of each study
and funding sources, may differ from one another. Therefore, this Task Order, will incorporate
multiple CLINs to properly administer the various program efforts and each distinct performance period and funding sources. The efforts required to support the core studies will be awarded under CLIN1: EAG Core Studies. Additional related work may be incorporated to this Task Order under separate CLINs.
本任务订单的目的是提供全面的行政、临床和研究支持,
为所有环境自身免疫组(EAG)临床研究提供统计、数据库和储存库管理以及监管协助。这包括:受试者筛选、评价和处置;根据需要填写方案表格;安排和管理现场和非现场入组流程;数据库创建、融合和更新;数据清理和分析;样本采集和储存、交付和处理;确保按照任何标准操作规程(SOP)完成所有调查问卷和知情同意书修订或卫生与公众服务部、国防部、食品和药物管理局、退伍军人事务部、任何其他监督部门所需的其他变更和其他行政程序
机构和其他合作实体的规则和条例。
本任务指令将为EAG临床研究提供支持,其中服务可分类
作为可分割和不可分割,完成每项研究所需的履约期
和资金来源,可能彼此不同。因此,本任务指令将纳入
多个项目经理,以正确管理各种计划工作和每个不同的绩效期和资金来源。支持核心研究所需的努力将在EAG核心研究下获得奖励。其他相关工作可根据单独的任务指令并入本任务指令。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NASTARAN BAYAT其他文献
NASTARAN BAYAT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NASTARAN BAYAT', 18)}}的其他基金
TASK ORDER 4R - ENVIRONMENTAL AUTOIMMUNITY GROUP (EAG) - STUDY SUPPORT
任务顺序 4R - 环境自身免疫组 (EAG) - 研究支持
- 批准号:
10847306 - 财政年份:2021
- 资助金额:
$ 19.87万 - 项目类别:
相似海外基金
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
- 批准号:
10707830 - 财政年份:2023
- 资助金额:
$ 19.87万 - 项目类别:
Hospital characteristics and Adverse event Rate Measurements (HARM) Evaluated over 21 years.
医院特征和不良事件发生率测量 (HARM) 经过 21 年的评估。
- 批准号:
479728 - 财政年份:2023
- 资助金额:
$ 19.87万 - 项目类别:
Operating Grants
Analysis of ECOG-ACRIN adverse event data to optimize strategies for the longitudinal assessment of tolerability in the context of evolving cancer treatment paradigms (EVOLV)
分析 ECOG-ACRIN 不良事件数据,以优化在不断发展的癌症治疗范式 (EVOLV) 背景下纵向耐受性评估的策略
- 批准号:
10884567 - 财政年份:2023
- 资助金额:
$ 19.87万 - 项目类别:
AE2Vec: Medical concept embedding and time-series analysis for automated adverse event detection
AE2Vec:用于自动不良事件检测的医学概念嵌入和时间序列分析
- 批准号:
10751964 - 财政年份:2023
- 资助金额:
$ 19.87万 - 项目类别:
Understanding the real-world adverse event risks of novel biosimilar drugs
了解新型生物仿制药的现实不良事件风险
- 批准号:
486321 - 财政年份:2022
- 资助金额:
$ 19.87万 - 项目类别:
Studentship Programs
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
- 批准号:
10676786 - 财政年份:2022
- 资助金额:
$ 19.87万 - 项目类别:
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
- 批准号:
10440970 - 财政年份:2022
- 资助金额:
$ 19.87万 - 项目类别:
Improving Adverse Event Reporting on Cooperative Oncology Group Trials
改进肿瘤学合作组试验的不良事件报告
- 批准号:
10642998 - 财政年份:2022
- 资助金额:
$ 19.87万 - 项目类别:
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
- 批准号:
10482465 - 财政年份:2022
- 资助金额:
$ 19.87万 - 项目类别:
Expanding and Scaling Two-way Texting to Reduce Unnecessary Follow-Up and Improve Adverse Event Identification Among Voluntary Medical Male Circumcision Clients in the Republic of South Africa
扩大和扩大双向短信,以减少南非共和国自愿医疗男性包皮环切术客户中不必要的后续行动并改善不良事件识别
- 批准号:
10191053 - 财政年份:2020
- 资助金额:
$ 19.87万 - 项目类别:














{{item.name}}会员




